A new study is set to investigate how AI could significantly improve doctors’ decisions regarding prostate cancer treatment. While diagnostic methods for the disease have become safer and more precise ...

ZERO Prostate Cancer (ZERO) announces the launch of ZACH (ZERO's Access to Community Health), the first SMS-based AI support ...

CDX Prostate is a blood-based diagnostic tool that uses AI-powered learning to determine the risk of aggressive prostate cancer. Florida-based Protean BioDiagnostics will now offer the validated CDX ...

Sept. 18, 2025 -- About 1 in 8 men will face a prostate cancer diagnosis. Early-stage prostate cancer often has no symptoms—so how should men approach screening and advocacy? What disparities do Black ...

CLEVELAND, Ohio — When it comes to cancer, deciding on the best course of treatment can sometimes feel like a coin toss. However, doctors at University Hospitals have a new tool that helps them weigh ...

The UCLA trial is currently enrolling patients. Clinical trial compares two targeted radiation therapies for recurrent prostate cancer. New AI tool, ProCUSNet, detects prostate cancer more accurately ...

Prostate health stands as a cornerstone of overall well-being, with particular importance for Black men who can significantly benefit from understanding their father’s health history. This article ...

What should men know about prostate cancer? Early detection of prostate cancer is critical, and researchers are developing a new urine test that may improve accuracy over traditional PSA screening.

Prostate cancer is the most common form of cancer among men in Western countries. The disease is naturally linked to aging. Professor Tone Frost Bathen at NTNU leads a number of research projects on ...

Prostate cancer is typically a misunderstood yet common type of cancer among men even as screening protocol may contribute to a less urgent approach toward the disease. With news that former President ...

Comparison of Patient-Reported Peripheral Neuropathy Among Patients Treated With Elranatamab Versus Real-World Clinical Practice in Triple-Class Refractory Multiple Myeloma To our knowledge, no ...

Prostate cancer is a topic that affects men of all races and ethnicities, but it’s essential to recognize that certain groups face a higher risk than others. Among these, Black men are at an increased ...